Development of a sensitive multiplexed open circuit potential system for the detection of prostate cancer biomarkers by Wong, Lai Chun Caleb et al.
        
Citation for published version:
Wong, LCC, Jolly, P & Estrela, P 2018, 'Development of a sensitive multiplexed open circuit potential system for
the detection of prostate cancer biomarkers', BioNanoScience, vol. 8, no. 2, pp. 701-706.
https://doi.org/10.1007/s12668-017-0408-0
DOI:
10.1007/s12668-017-0408-0
Publication date:
2018
Document Version
Peer reviewed version
Link to publication
The final publication is available at Springer via http://dx.doi.org/10.1007/s12668-017-0408-0
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 13. May. 2019
Full Paper                                                            BioNanoScience 
Development of a sensitive multiplexed open circuit potential system for 
the detection of prostate cancer biomarkers 
Lai Chun Caleb Wong, Pawan Jolly, Pedro Estrela * 
Department of Electronic & Electrical Engineering, University of Bath, Bath BA2 7AY, United Kingdom 
  
*Corresponding author: Department of Electronic & Electrical Engineering,  
    University of Bath,  
Claverton Down, Bath, BA2 7AY, United Kingdom 
E-mail: P.Estrela@bath.ac.uk  
Phone: +44-1225-386324 
 
Abstract 
 
We report the development of a sensitive label-free, cost-effective detection system with simultaneous multi-channel 
measurement of open circuit potential (OCP) variations for the detection of prostate specific antigen (PSA). We demonstrate 
a significant increase of 600 times in the sensitivity as compared to the reported literature. To accurately measure OCP 
variations, a complete monolithic field-effect transistor (FET)-input ultra-low input bias current instrumentation amplifier is 
used to form the electronic circuit to measure the variation between a working electrode and a reference electrode. This 
amplifier electronic system setup provides a differential voltage measurement with high input impedance and low input bias 
current. Since no current is applied to the electrochemical system, a true and accurate measurement of the variation can be 
performed. This is the first report on the use of DNA aptamers with OCP system where we employed a DNA aptamer 
against PSA. An optimised ratio of anti-PSA DNA aptamer with 6-mercapto-1-hexanol (MCH) was used to fabricate the 
aptasensor using gold electrodes. The electrodes are hosted in a cell with an automated flow system. A wide range of 
concentrations of PSA (0.1 ng/mL to 100 ng/mL) were injected through the system. The sensor could potentially 
differentiate 0.1 ng/mL PSA from blank measurement, which is well below the required clinical range (>1 ng/mL). The 
sensor was also challenged with 4% human serum albumin and human kallikrein2 as control proteins where the sensor 
demonstrated excellent selectivity. The developed system can be further generalised to various other targets using specific 
probes.  
Keywords: aptamer, prostate cancer diagnosis, prostate specific antigen, open circuit potential  
 
1. Introduction 
Label-free technologies have gained a high interest in the 
past decade for the development of biosensors that could 
achieve high throughput screening capabilities. In a recent 
report, the global label-free detection market was valued at 
USD 1.22 Billion in 2015, and expected to reach USD 2.13 
Billion by 2020, at a compound annual growth rate of 
11.86% from 2015 to 2020 [1]. Label-free technologies 
provide opportunities for probing biomolecular interactions 
without spatial interference, steric hindrance, auto-
fluorescent and quenching effects of labels. Freeing from a 
preparatory step for labelling (dyes, tags, or specialized 
reagents), increasing the throughput screening targets at a 
single time and, consequently, lowering the overall cost of 
the system. Conventional label-based technologies, 
however, are usually labour intensive, time consuming and 
cumbersome, resulting in a higher cost when compared to 
label-free technologies. Thus an increasing amount of 
studies based on label-free detection technologies have been 
made with different detection methods [2-8]. In the field of 
electrochemical sensing, different detection techniques have 
been introduced to use label-free technologies, such as 
electrochemical impedance spectroscopy (EIS) and 
differential pulse voltammetry (DPV). However, these 
techniques still rely on the use of redox markers to 
distinguish the reaction on the biolayer, which has put 
pressing needs on the development of novel technologies. 
To take up such a challenge, an open circuit potential (OCP) 
detection technique finds its right application. 
OCP variations can be used to detect biomolecular 
interactions on a metal electrode. This potentiometric 
detection technique is the direct measurement of potential 
Full Paper                                                            BioNanoScience 
variations brought about by changes in the net charge or 
capacitance on the biolayer. The variation during 
binding/attachment of biomolecules can then be monitored 
in real time. Direct OCP measurements cannot be achieved 
in an accurate way with standard potentiostats due to their 
circuit architecture. To date, there has been only few reports 
on the use of OCP as a detection technique. For instance, 
Estrela et al. [9] first demonstrated that electrical detection 
of protein interactions can be achieved by the direct 
measurement of OCP variations through an instrumentation 
amplifier using a single channel for detection. Such system 
presents an alternative to the use of metal-gate field effect 
transistors (BioFET), where OCP variations on the metal 
gate cause a shift on the threshold voltage of the BioFET 
[10]. Mello et al. [11] demonstrated the use of 
instrumentation amplifiers for pH sensing using polyaniline 
films and Harb et al. [12] discussed the relations of OCP to 
nanocomposites.  
For many biosensing applications there has been increasing 
interest in the use of aptamers. Although antibodies have 
dominated commercial adoption, aptamers provide a wide 
range of advantageous properties such as long-term stability, 
affordability and ease of development compared to 
antibodies [13,14]. They can also be regenerated without 
loss of integrity or selectivity [15]. There are plenty of 
reports covering the development of aptasensors based on 
different detection techniques from optical to 
electrochemical routes. However, in the niche of 
potentiometric sensors, OCP had still not been investigated.   
We therefore present for the first time a sensitive label-free 
detection flow system with simultaneous multi-channel 
measurement of OCP variations for the detection of prostate 
specific antigen (PSA) as a case study. PSA is a 30 kDa 
protein found in blood which is the sole biomarker currently 
used for prostate cancer (PCa). PCa is the most commonly 
diagnosed cancer amongst men in Europe and the United 
States, and is the second-highest cause of cancer-related 
morbidity worldwide [16]. Changes in PSA levels in the 
blood can be used for PCa screening with levels higher than 
the cut-off level of 4 ng/mL prompting biopsy procedures to 
be considered [16-19]. 
We have used anti-PSA aptamer to detect different 
concentrations of PSA using the OCP technique. We have 
previously demonstrated the optimisation of different 
surface chemistries for PSA aptamer-based impedimetric 
sensors; although high sensitivity has been obtained for 
novel approaches, we note that for a simple aptamer / 
mercaptohexanol self-assembled monolayer, a detection 
limit of 60 ng/mL has been obtained [20], which is much 
higher than the clinical range. In the present study, we have 
used a similar approach to prepare electrode surfaces with 
DNA aptamers and detected PSA in real time. A very low 
detection of 0.1 ng/mL which is 600 times increased 
sensitivity than using electrochemical impedance 
spectroscopy as a detection technique. The aptasensor 
developed demonstrated a good selectivity when challenged 
with control proteins such as human Kallikrien 2 (hK2) and 
human serum albumin (HSA). We present a simple 
instrumentation system with a sensitive detection limit that 
could be easily generalised to other probes for the detection 
of various other biomarkers and easily realise multiplexed 
detection.  
2. Materials & Methods 
2.1. OCP electronic design 
The amplifier electronic system setup provides a differential 
voltage measurement with high input impedance and low 
input bias current. Since no current is applied to the 
electrochemical system, a true and accurate measurement of 
the variation can be performed. To accurately measure OCP 
variations, a complete monolithic FET-input ultra-low input 
bias current instrumentation amplifier INA116 (Texas 
Instruments, USA) is used to form the electronic detection 
circuit, measuring the variations between the working 
electrode and the reference electrode (see Figure 1). A Pt 
wire is used to ground the electrolyte. A stable and isolated 
±15 V power circuit supplies the power specifically for the 
instrumentation amplifier to improve the working condition 
of the amplifier to the maximum performance. A DC/DC 
converter MCA05D15S (Multicomp, USA) was selected to 
supply an isolated ±15 V (setpoint accuracy ±3%) with a 
maximum peak-to-peak ripple of 75 mV measured with a 
20 MHz bandwidth. This power supply and connected 
power lines are separated from all other signal lines or 
power lines of other electronics. The differential 
measurement outputs (V0) from the amplifiers are then 
passed into an analog-to-digital converter (ADC). 
 
Fig. 1 Schematic of the basic design of a single channel 
OCP measurement system. WE is the working electrode; RE 
the reference electrode; the Pt wire is grounding the 
solution. 
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The overall closed-loop gain (𝐺) of the instrumentation 
amplifier can be described as 
 
𝐺 = 1 +
50𝑘Ω
𝑅𝐺
 (1) 
where 𝑅𝐺 is the single gain-setting external resistor. To 
eliminate any further errors that can be caused by the 
mismatch of multi-channel electronic components, the 
amplifiers of all channels are set to unity gain differential 
configuration (G = 1).  
A 24-bit, 4-channel, simultaneous-sampling, sigma-delta 
analog-to-digital converter (ADC) MAX11040K (Maxim 
Integrated, USA) is selected for sampling the differential 
outputs of the instrumentation amplifiers, which are the 
OCP analog signals. The differential analog input range is 
±2.2 V when using the internal reference voltage (VREFIO), 
which is well within the input OCP signal. Code transitions 
occur halfway between successive integer least significant 
bit (LSB) values with 1 LSB = (0.88 x VREFIO) x 
2/16,777,216 in 24-bit mode. This ADC allows high 
resolution and simultaneous sampling of 4 channels on its 
own (see Figure 2) and up to 32 channels by using a built-in 
cascade feature to synchronize as many as eight devices on a 
single serial interface. The simplicity of the device allows 
reading data from all the cascaded devices using a single 
command, with the eight devices effectively operating as 
one device. In the current design, a single ADC is used, 
which gives a 4-channel simultaneous-sampling system.  
An Arduino UNO (Arduino, USA) is used as the main 
controller. Stacked on top with a module board that hosted 
the INA116 instrumentation amplifiers and the 
MAX11040K ADC. Digital data is outputted from the ADC 
through a microprocessor into a computer, and monitored 
through a LabVIEW program in real time.  
 
Fig. 2 Schematic of the multiplexed OCP detection circuit 
constructed with four INA116 instrumentation amplifiers 
and one MAX11040K ADC. 
2.2. Electrochemical characterization 
OCP measurements were carried out using the custom made 
electronic measurement system based on the INA116 ultra 
low input bias current instrumentation amplifiers design. 
The simultaneous measurement setup, illustrated in Figure 
3, consisted of a linear array of four working electrodes with 
a radius of 2.0 mm, an Ag/AgCl (3 M NaCl) reference 
electrode (BASi, USA), and a platinum wire (ALS Co., 
Japan) for grounding the solution in the electrochemical cell. 
The working electrode linear array was prepared in-house 
by thermal evaporation (BOC Edwards, USA) with 20 nm 
chromium and 100 nm gold on a glass slide. The OCP was 
measured in a solution of 10 mM phosphate buffer (PB) 
(pH 7). The reference electrode was connected via a salt 
bridge filled with the same 10 mM PB (pH 7) solution. The 
OCP was recorded in real time; solutions of PSA from the 
lowest to the highest concentrations were injected into the 
flow cell. A multiplexed design of four working electrodes 
was measured at the same time through four different 
channels for the potential changes, by using a common 
reference electrode. Binding studies were carried out under a 
flow rate of 100 μl/min using a peristaltic pump (323-Du, 
Watson Marlow, UK) and an in-house built 
polytetrafluoroethylene (PTFE) flow cell with an inner 
chamber of approximate dimensions 25 × 8 × 5 mm3 (length 
× width × height) and an internal volume of 1 ml. 
 
Fig. 3 (a) An illustration of the whole OCP system setup, 
including the fabricated PSA aptasensor loaded in a flow 
cell. (b) A photo of the flow cell and circuit board. 
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2.3. Fabrication of PSA aptasensor 
Experiments with PSA aptamer were performed using the 
gold evaporated electrodes following a previously reported 
protocol [20-21]. Briefly, the clean gold electrodes were 
exposed to 5 µl of immobilization solution containing 
thiolated DNA aptamer and 6-mercapto-1-hexanol (MCH, 
Sigma, UK) for 16 h in a humidity chamber. An optimized 
0.5% DNA aptamer mole fraction to total thiol was used to 
fabricate the biosensor [21]. A high concentration of MCH 
(10 mM) was prepared in pure ethanol which was then 
diluted in 10 mM PB (pH 7) to the required working 
concentrations. Prior to addition of MCH, DNA aptamers 
were heated to 95 °C for 10 min followed by gradual 
cooling over 30 min to room temperature [19]. After 
immobilization, the electrodes were rinsed with excess 
MilliQ water to remove unattached thiols. In order to ensure 
complete thiol coverage of the gold surface, the electrodes 
were thereafter backfilled with 1 mM MCH for 1 h. The 
electrodes were then rinsed with MilliQ water and placed in 
10 mM PB (pH 7) for stabilization.  
2.4. Binding studies 
The fabricated DNA aptamer modified electrodes were 
hosted in a cell with an automated flow system. Injections of 
analyte were performed in 15 minute intervals under a flow 
rate of 100 μl/min. Different concentrations of PSA from 
0.1 ng/mL to 100 ng/mL were prepared in 10 mM PB (pH 7) 
from stock solutions. Control proteins such as 100 ng/ml 
hK2 and 66 mg/ml HSA were also prepared in 10 mM PB 
(pH 7). 
3. Results and discussion 
3.1. Real time OCP measurements 
By using a potentiostat for the measurement of OCP, the 
circuit architecture applies a very small current into the 
electrochemical system, and measures the response from the 
electrochemical system in order to obtain the OCP. 
Therefore, these systems are not measuring in true open 
circuit. The use of carefully selected instrumentation 
amplifiers enables a direct and precise measurement of OCP 
variations. With this design, no current is applied to the 
electrochemical system when measuring the OCP and 
therefore effects that can be caused by passing current 
through the electrochemical interface can be eliminated.  
The current design of the system is a stackable electronic 
design, with one main controller as the base board. Each 
module boards have 4 channels for OCP sensing. Extra 
boards of the INA116 instrumentation amplifiers circuit can 
be stacked on top of each other, increasing the system 
capability of simultaneous detection from 4 channels to 32 
channels. This can be done as the expansion module board 
communicates on a single serial interface with the 
controller. In addition, extra devices are allowed to the 
system by connecting through extra serial interfaces, 
allowing the system to be expanded into a high-channel 
multiplexed OCP measurement setup.  
The OCP data was monitored by a computer in real time for 
live display and recording. Every step of the measurement is 
illustrated through a voltage (OCP) vs time graph. Thus, 
even the smallest changes can be viewed in real time during 
the experiment. The data is recorded into a table with 
timestamp and OCP value and saved in a spreadsheet 
format. Variations of the OCP values show the binding 
activity of the biomolecules, and further analysis such as 
dose response can be obtained through calculation and 
comparison analysis.  
Figure 4 shows real time OCP data for the fabricated 
aptasensor upon injection of different concentrations of PSA 
in four separate channels of the linear array of electrodes. 
The OCP value decreases for increasing concentrations of 
PSA (starting from 0.01 ng/ml), until it reaches saturation at 
around 20 ng/ml (ΔVOCP ~ -3 mV). As a control, samples 
containing the same volume of buffer without any PSA were 
also injected into the cell; no significant further variations in 
OCP were observed, indicating the variations measured are 
due to binding of PSA. It is worth mentioning that spikes in 
the measurements are observed when buffer or PSA sample 
enters the chamber but the values stabilise after 15 min. As 
shown in the inset of Figure 4, upon injection of buffer, the 
OCP returns to its original value. All four channels give 
identical responses to both PSA and buffer injections. 
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Fig. 4 A typical OCP behaviour of the aptasensor with the 
response of consecutive injections of different 
concentrations of PSA (black arrows) and rinsing buffer 
(blue arrows) on four separate electrodes of the array. The 
numbers next to the black arrows indicate the PSA 
concentrations injected. The inset shows the initialization of 
the OCP measurement with an injection of buffer (blank 
solution). 
3.2. Analytical and selectivity performance 
A dose response was obtained using all the four channels 
and is presented in Figure 5. An OCP signal change of 
-0.880 ± 0.005 mV is observed for 0.1 ng/ml of PSA, 
decreasing down to -2.850 ± 0.020 mV for 20 ng/ml. Such a 
decrease in the OCP signal could be attributed to the 
combined effect of folding of DNA aptamer and the charge 
of PSA at pH 7. Upon binding of PSA to the immobilised 
DNA aptamer, the DNA aptamer undergoes a change in 
conformation causing more negative charges closer to the 
electrode surface. It is likely that the PSA is either neural or 
negatively charged depending upon the amount of 
glycosylation sites. Further injections of PSA do not change 
this saturation signal. A linear response is obtained from 
0.1 ng/ml to 10 ng/ml with an R2 value of 0.99. The sensor 
can differentiate 0.1 ng/ml from blank measurements, which 
is well below the required clinical range (>1 ng/ml).  
 
Fig. 5 Dose response of the aptasensor. The points represent 
the average for 4 channels. The line represents a linear fit to 
the points between 1 and 10 ng/ml (as shown in the inset 
using a linear scale).  
The sensor was further challenged with two control proteins: 
human serum albumin (HSA, 4%) and human Kallikrein2 
(hK2, 100 ng/mL). hK2 is another serine protease from the 
same kallikrein family as PSA and was chosen as a stringent 
control protein since is it shares 80% homology with PSA. 
Although the levels of hK2 in clinical samples are 100 fold 
lower than that of PSA, a much higher concentration of 
100 ng/ml of protein was used to stringently evaluate the 
aptamer based detection of PSA [22]. A negligible change 
with hK2 (-0.174 ± 0.025 mV) was observed as compared to 
the signal change from PSA with same concentration 
(-2.900 ± 0.018 mV) – see Figure 6. This clearly indicates 
the specificity of the aptamer towards PSA. As a further 
control, 4% HSA (~66 mg/ml) was used since it is a major 
constituent of blood. A change of +1.100 ± 0.024 mV was 
observed with HSA in the opposite direction as of PSA.  
Such a signal change with HSA could be attributed to non-
specific interaction of HSA with the SAM. A similar 
response has been previously reported for impedance PSA 
aptasensors [20-21].  
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Fig. 6 A comparison of response with blank, hK2 
(100 ng/ml), HSA (66000 ng/ml) and PSA (100 ng/ml) 
fabricated sensors. 
4. Conclusions 
We have presented a sensitive label free, cost effective OCP 
system that can be used to develop sensitive aptasensors. In 
its present configuration, with one instrumentation amplifier 
per channel and one ADC per 4 channels, the circuitry costs 
around $50 per 4 channels using off-the shelf components, 
making the system an attractive cost effective alternative to 
other electrochemical systems. The aptasensor developed for 
PSA using this OCP detection technique demonstrated a 600 
times increased sensitivity with similar aptasensor using 
electrochemical impedance spectroscopy. The sensor 
displayed good selectivity when challenged with stringent 
control proteins. PSA was used as case study to show the 
applicability of the technique and the robustness of the 
multichannel approach. This strategy can be easily adopted 
for the detection of a wide range of biomarkers in a 
multiplexed platform using not only aptamers but also other 
receptor molecules such as peptides, antibodies and lectins.  
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Figure captions 
Fig. 1 Schematic of the basic design of a single channel OCP measurement system. WE is the working electrode; RE the 
reference electrode; the Pt wire is grounding the solution. 
Fig. 2 (a) An illustration of the whole OCP system setup, including the fabricated PSA aptasensor loaded in a flow cell. (b) 
A photo of the flow cell and circuit board. 
Fig. 3 An illustration of the whole OCP system setup, including the fabricated PSA aptasensor loaded in a flow cell. 
Fig. 4 A typical OCP behaviour of the aptasensor with the response of consecutive injections of different concentrations of 
PSA (black arrows) and rinsing buffer (blue arrows) on four separate electrodes of the array. The numbers next to the black 
arrows indicate the PSA concentrations injected. The inset shows the initialization of the OCP measurement with an 
injection of buffer (blank solution). 
Fig. 5 Dose response of the aptasensor. The points represent the average for 4 channels. The line represents a linear fit to the 
points between 1 and 10 ng/ml (as shown in the inset using a linear scale). 
Fig. 6 A comparison of response with blank, hK2 (100 ng/ml), HSA (66000 ng/ml) and PSA (100 ng/ml) fabricated sensors. 
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